10 high-profitability small-cap stocks with lowest YTD performance in 2026
Seeking Alpha News (Mon, 13-Apr 5:10 PM ET)
Globe Newswire (Tue, 17-Mar 5:11 PM ET)
Globe Newswire (Mon, 16-Mar 8:00 AM ET)
Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm
Globe Newswire (Fri, 13-Mar 1:38 PM ET)
Globe Newswire (Tue, 10-Mar 1:52 PM ET)
INVESTOR ALERT: Investigation of Nutex Health, Inc. (NUTX) announced by Holzer & Holzer, LLC
Globe Newswire (Fri, 6-Mar 4:09 PM ET)
Globe Newswire (Fri, 6-Mar 10:21 AM ET)
Nutex Health's Revenue Surges 82% in 2025 as Stock Buyback Signals Confidence
Market Chameleon (Fri, 6-Mar 2:29 AM ET)
NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM
PRNewswire (Thu, 5-Mar 6:34 PM ET)
PRNewswire (Wed, 25-Feb 5:30 PM ET)
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
Nutex Health trades on the NASDAQ stock market under the symbol NUTX.
As of April 16, 2026, NUTX stock price declined to $103.61 with 403,479 million shares trading.
NUTX has a beta of 2.71, meaning it tends to be more sensitive to market movements. NUTX has a correlation of 0.10 to the broad based SPY ETF.
NUTX has a market cap of $721.99 million. This is considered a Small Cap stock.
Last quarter Nutex Health reported $152 million in Revenue and $1.61 earnings per share. This fell short of revenue expectation by $-107 million and missed earnings estimates by -$3.95.
In the last 3 years, NUTX traded as high as $193.07 and as low as $4.16.
The top ETF exchange traded funds that NUTX belongs to (by Net Assets): AVUV, VTI, IWM, VXF, SFLO.
NUTX has underperformed the market in the last year with a price return of -25.4% while the SPY ETF gained +31.8%. NUTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -36.9% and +5.3%, respectively, while the SPY returned +1.6% and +7.0%, respectively.
NUTX support price is $104.27 and resistance is $113.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUTX shares will trade within this expected range on the day.
